inBiome is a company headquartered in the Netherlands. Brouky records 1 investor associated with the company.
inBiome develops Molecular Culture technology that enables same-day bacterial identification directly from blood to accelerate diagnostics and improve treatment decisions in sepsis and other infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.